CBG takes the top spot in this comparison. It has the widest base of published lab and animal research among the minor cannabinoids, it does not get you high, and it is sold in forms that let you repeat a dose. The other picks, CBN, CBC, and THCV, are ranked on four criteria: how much human evidence exists, how clear the mechanism is, tolerability at common doses, and whether the label tells you enough to dose the same way twice.
cannabis cannabinoids list and effects
CBG (cannabigerol): best overall evidence base
CBG is the parent molecule that other cannabinoids are built from in the plant, and it appears in measurable amounts in some cultivars. Most of what is known comes from laboratory and animal work.
cannabis cannabinoids list and effects
- Pros: non-intoxicating, so it can be stacked with THC or CBD; studied for inflammation, pain signaling, and appetite in preclinical models; available as isolate, oil, gummy, and in flower.
- Cons: controlled human trials are few; marketing runs ahead of the data; labels often omit the actual milligram content per serving.
Use case: a daytime, clear-headed option for someone who wants a non-intoxicating cannabinoid and accepts that the supporting research is early.
CBN (cannabinol): the evening pick
CBN forms as THC breaks down, so it shows up in older flower and in aged extracts. It is a common ingredient in sleep-oriented products, usually paired with THC.
Marijuana Chemical Compounds Explained: Cannabinoids, Terpenes, and More
- Pros: non-intoxicating on its own; blends well with THC for nighttime products; occurs naturally in aged material.
- Cons: the sleep reputation rests on anecdotal reports and a small number of studies, some of which tested CBN with THC rather than alone; sedation users notice may come from the THC in the blend.
Use case: evening users who already tolerate THC and want a heavier, quieter effect.
CBC (cannabichromene): the entourage partner
CBC is one of the more common minor cannabinoids in whole-plant extracts and is often included in full-spectrum products without appearing on the front of the package.
- Pros: preclinical work looks at pain and inflammation pathways; non-intoxicating; found alongside CBD and CBG in many cultivars.
- Cons: almost no human data; amounts in finished products are small and often undisclosed; the name is easy to confuse with CBD in advertising.
Use case: buyers who prefer a full-spectrum extract and want a wider spread of plant compounds instead of a single isolate.
THCV (tetrahydrocannabivarin): the metabolic and focus angle
THCV is a THC analog with a shorter side chain, and its interaction with the CB1 receptor differs from THC in ways researchers are still mapping. It is usually sold in small quantities in vape carts and blends.
- Pros: distinct pharmacology that draws interest in appetite and glucose research; low doses are reported as clear-headed rather than foggy; pairs with daytime routines.
- Cons: intoxicating at higher doses; human studies are thin and small; supply is limited and labels sometimes report THCV and THCVA together without separating them.
Use case: experienced users who want a lighter, more alert profile than standard THC flower.
Criterion: reading the evidence tiers
Nearly every claim about minor cannabinoid benefits sits in the first tier: cells in a dish, then mice and rats. Above that sit observational studies in people, then small controlled trials, then large randomized trials and systematic reviews. When a product page cites a study, check which tier it came from. A mouse study on joint swelling is not a claim about your knee.
Criterion: label and dosing checks
- Look for a batch-specific certificate of analysis from a third-party lab, not a generic PDF.
- Find milligrams of each cannabinoid per serving, not just total cannabinoids per container.
- Note the batch or harvest date, since THC converts to CBN over time.
- Confirm whether the product is isolate or full spectrum, because the two behave differently at the same CBD or CBG number.
Criterion: safety and legal status
The FDA has not approved any minor cannabinoid as a treatment for a disease, and these products sit in the state-legal market rather than the supplement aisle. Minor cannabinoids can interact with prescription drugs, including blood thinners and seizure medications, so talk with a clinician if you take anything daily. THCV products can impair driving at higher doses. Start low, keep the package, and change one variable at a time so you know what actually did something.